BLA
MED icon

Balter Liquid Alternatives’s Medifast MED Stock Holding History

Balter Liquid Alternatives’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,500
Closed -$191K – 162
2019
Q1 		$191K Sell
1,500
-3,335
-69% -$423K 0.11% 155
2018
Q4 		$604K Buy
+4,835
New +$827K 0.42% 88
2018
Q3 		– Sell
-2,900
Closed -$462K – 229
2018
Q2 		$462K Buy
+2,900
New +$371K 0.36% 97

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Balter Liquid Alternatives's MED Position: Q2 2019 in Review

Balter Liquid Alternatives sold out of Medifast (MED) in Q2 2019, closing a stake of 1,500 shares — an estimated $191K sold.

Balter Liquid Alternatives first reported a position in MED in Q2 2018 and held it in 3 quarters. The position peaked at $604K in Q4 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

  • Balter Liquid Alternatives reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
  • Balter Liquid Alternatives sold 1,500 Medifast shares in Q2 2019, an estimated $191K.
  • Balter Liquid Alternatives first reported a position in Medifast in Q2 2018 and held it in 3 quarters.
  • Balter Liquid Alternatives's Medifast position peaked at $604K in Q4 2018.
  • 251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on Balter Liquid Alternatives's 13F filing for Q2 2019, filed 31 Jul 2019.